Acute respiratory distress syndrome.

Rob Mac Sweeney, Daniel F McAuley

Journal: Lancet (London, England) 2017;388(10058):2416-2430

PMID: 27133972

Abstract

Acute respiratory distress syndrome presents as hypoxia and bilateral pulmonary infiltrates on chest imaging in the absence of heart failure sufficient to account for this clinical state. Management is largely supportive, and is focused on protective mechanical ventilation and the avoidance of fluid overload. Patients with severe hypoxaemia can be managed with early short-term use of neuromuscular blockade, prone position ventilation, or extracorporeal membrane oxygenation. The use of inhaled nitric oxide is rarely indicated and both β agonists and late corticosteroids should be avoided. Mortality remains at approximately 30%.

Copyright © 2016 Elsevier Ltd. All rights reserved.

Address: Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK.; Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, Northern Ireland, UK; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Belfast, Northern Ireland, UK. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.